戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              BCA attenuated stroke lesion volume as measured by 9.4T
2                                              BCA increased luciferase activity in cells that were tra
3                                              BCA levels were significantly increased in plasma and br
4                                              BCA removes Cu(I) from Atox1 in a three-step process inv
5                                              BCA significantly increased GOT mRNA and protein express
6                                              BCA was defined as elevated levels of insulin autoantibo
7                                              BCA-1 (CXCL13) was completely absent in control biopsy s
8                                              BCA-1 (CXCL13) was expressed within lymphoid aggregates
9                                              BCA-1/CXCL13, which mediates homing to B cell zones, eli
10               B cell-attracting chemokine 1 (BCA-1) responses correlate with CXC chemokine receptor (
11 expression of B cell-attracting chemokine 1 (BCA-1, CXCL13), a lymphoid chemokine involved in B-cell
12  for elevated B-cell-attracting chemokine 1 (BCA-1; fourth quartile vs first: odds ratio [OR], 2.7; 9
13 ysis of the model showed that the rates of a BCA colonising diseased and/or healthy plant tissues and
14 l of phytoestrogen isoflavones, biochanin A (BCA) was identified as the most potent inducer of GOT ge
15  the 26 competing oligomers (i.e., AAA, ABB, BCA).
16          Balanced chromosomal abnormalities (BCAs) represent a relatively untapped reservoir of singl
17 Vs), but balanced chromosomal abnormalities (BCAs) still require karyotyping for clinical detection.
18 cance of balanced chromosomal abnormalities (BCAs), their characterization has largely been restricte
19 : Nafion, base-hydrolyzed cellulose acetate (BCA), and fibronectin.
20 y using the Cu(I) chelator bicinchonic acid (BCA) as a metal acceptor.
21 fication to the standard bicinchoninic acid (BCA) assay protocol allows for an accurate, rapid, and e
22 d using Western blot and bicinchoninic acid (BCA) assay.
23 s were determined by the Bicinchoninic acid (BCA) method, Ara h 1 and Ara h 2 were evaluated by SDS-P
24 hich is analogous to the bicinchoninic acid (BCA) protein assay widely used in proteomics, will be ap
25 ma levels of the branched chain amino acids (BCAs) leucine/isoleucine and their deaminated metabolite
26 ssociation to form free catalytically active BCA along with CB[7]*1 and CB[7]*2.
27 lective method for boron conjugate addition (BCA) to alpha,beta-unsaturated carbonyls is presented.
28  enantioselective boryl conjugate additions (BCAs) that generate products containing boron-substitute
29 ics of foliar pathogen and biocontrol agent (BCA) populations in order to predict the likelihood of s
30 of developing bifunctional chelating agents (BCAs), this new synthetic strategy offers the possibilit
31             Using biological control agents (BCAs) is an essential component of integrated pest and d
32 is a gold NP-based biobarcode amplification (BCA) assay, which can detect HIV-1 p24 antigen at levels
33 rategy using DNA-bio-bar-code amplification (BCA) and Nb.BbvCI nicking enzyme-assisted strand cycle f
34 roscopy and biomolecular component analysis (BCA) for a comparative analysis of the molecular composi
35 ng gene data, Bayesian Concordance Analysis (BCA), as implemented in the BUCKy software, in which the
36               Addition of CB[7] to BCA*1 and BCA*2 results in the transient formation of the BCA*1*CB
37 e transient formation of the BCA*1*CB[7] and BCA*2*CB[7] ternary complexes that undergo rapid dissoci
38                                 Both BCA and BCA-Ac(18) are catalytically active, and circular dichro
39 da, also had no detectable levels of GCA and BCA.
40 ed the effects of bovine carbonic anhydrase (BCA) and CO2-rich gas streams on the carbonation rate of
41 two polypeptides--bovine carbonic anhydrase (BCA) and peracetylated BCA (BCA-Ac(18))--having the same
42 nity of unlabeled bovine carbonic anhydrase (BCA) for a variety of ligands (most of which are benzene
43 se) A, myoglobin, bovine carbonic anhydrase (BCA) II, hemoglobin (Hb), and the hemoglobin-haptoglobin
44 e active sites of bovine carbonic anhydrase (BCA) or acetylcholinesterase (AChE) and inhibit their ca
45 h carbon cloth anode (CCA) or biochar anode (BCA) were inserted into raw water saturated soils contai
46 ndothelium-removed bovine coronary arteries (BCAs) precontracted with 30 mmol/L KCl to the NO donor S
47 , lesion area at the brachiocephalic artery (BCA) was reduced dramatically by approximately 85% in fr
48                       Moreover, detection at BCA-coated CFMs can be tuned by altering hydrolysis time
49 bonic anhydrase (BCA) and peracetylated BCA (BCA-Ac(18))--having the same sequence of amino acids but
50                                         Both BCA and BCA-Ac(18) are catalytically active, and circula
51 GOx) and urease, measurements of proteins by BCA assay, analysis of pH, and concentration of antioxid
52    Remarkably, Cu(I) uptake from solution by BCA is much slower than the transfer from holo-Atox1, pr
53  the principal features of the NHC-catalyzed BCA and SCA processes are detailed.
54 he expression of the constitutive chemokines BCA-1 (CXCL13) and SDF-1 (CXCL12) in salivary glands fro
55        Our findings suggest that circulating BCA-1, sTNFR2, and sVEGFR2 are associated with NHL risk
56 of a second BCA to generate apo-Atox1 and Cu-BCA(2).
57 bimolecular formation of an initial Atox1-Cu-BCA complex followed by dissociation of Atox1 and the bi
58 isplacement of the protein from the Atox1-Cu-BCA intermediate by the second BCA.
59 ollicular B cell-attracting chemokine CXCL13/BCA-1, suggesting a novel follicular B-helper-like T cel
60 on vetch), which contains beta-cyanoalanine (BCA) and gamma-glutamyl beta-cyanoalanine (gammaGBCA) is
61 SE and CSE inhibited with beta-cyanoalanine (BCA) in both isolated CSE enzymes (p < 0.005) and in C6
62 tic acid (AOAA, 100 mum), beta-cyanoalanine (BCA, 500 mum) and hydroxylamine (HA, 100 mum), altered t
63 kers found in common vetch: ss-cyanoalanine (BCA) and gamma-glutamyl-ss-cyanoalanine (GCA).
64                         Biliary cystadenoma (BCA) and biliary cystadenocarcinoma (BCAC) are rare tumo
65                                      The DNA-BCA system contains a locked nucleic acid (LNA) modified
66 r mass, suggesting that vascular endothelial BCA-1 expression may be consequent to transcytosis.
67 The recoveriess were determined as 95.8% for BCA and 97.4% for gammaGBCA.
68 ned associated with NHL after adjustment for BCA-1, sTNFR2, and sVEGFR2.
69 specimens containing PCNSL were positive for BCA-1.
70 sitively for CXCR5, the primary receptor for BCA-1.
71 ilies of persons with IDDM were screened for BCA.
72 e effects, non-fungal BCA and strategies for BCA application, although with a cost in model tractabil
73 vs SCE for (PCA)Co(2) and 0.39 V vs SCE for (BCA)Co(2).
74  constants of several unlabeled ligands from BCA, using plots of levitation height versus time.
75 heterogeneity, fungicide effects, non-fungal BCA and strategies for BCA application, although with a
76 nd, although it is most applicable to fungal BCA systems, does not address a specific biocontrol syst
77 features that are remarkably similar to GCs, BCA-1 (CXCL13) and SDF-1 (CXCL12) may contribute to the
78 ysine-epsilon-NHCOCH(3) groups and generates BCA-Ac(18).
79 %) recurrences; 2 patients who initially had BCA recurred with BCAC.
80                                           If BCAs are treated with DPI under 21% O(2) and then expose
81  inhibitors to bovine carbonic anhydrase II (BCA II), the observed thermodynamic binding signature de
82 n complexes of bovine carbonic anhydrase II (BCA) and para-substituted benzenesulfonamide ligands wit
83 association of bovine carbonic anhydrase II (BCA) and para-substituted benzenesulfonamides with chain
84 NH3+ groups of bovine carbonic anhydrase II (BCA).
85 etalloprotein--bovine carbonic anhydrase II (BCA, EC 4.2.1.1)--on unfolding upon treatment with sodiu
86  to incubation for 30 min at 37 degrees C in BCA standard working reagent.
87        Data demonstrates that carbonation in BCA-amended reactors remained limited by CO2 supply, imp
88 gth-dependent manner, causing an increase in BCA mobility.
89                 Activation of sGC by SNAP in BCA homogenate was also eliminated when vessels were pre
90  were not greatly affected by the introduced BCA.
91 lyses of beta-cyanoalanine and (13)C labeled BCA is used as an internal standard in gammaGBCA analysi
92 munostaining on selected specimens localized BCA-1 to malignant B lymphocytes and vascular endotheliu
93 BCA increased, HA inhibited) and/or LY83583 (BCA increased, AOAA and HA inhibited).
94 sGC and inhibiting NO-elicited cGMP-mediated BCA relaxation.
95 n samples and compared with the Pierce Micro BCA Protein Assay Kit.
96 nitude more rapidly than the acetyl-modified BCA.
97 bic interactions cause the hexanoyl-modified BCA to denature nearly three orders of magnitude more ra
98                               Acetylation of BCA with acetic anhydride converts all 18 lysine-epsilon
99 n-off switching of the catalytic activity of BCA is delineated by the combined inference of UV/vis ca
100 nd increases the hydrophobic surface area of BCA.
101 tive site was probed by observing binding of BCA to a charged arylsulfonamide using affinity capillar
102                            Eighteen cases of BCA were detected; 153 unrelated autoantibody-negative c
103               Therefore the determination of BCA and gammaGBCA analytes in accurate and reliable mann
104                            After excision of BCA, long-term outcomes were good; however, patients wit
105                    The ectopic expression of BCA-1 (CXCL13) on endothelial cells and within GC-like s
106                      In PCNSL, expression of BCA-1 by malignant lymphocytes and vascular endothelium
107 itu hybridization verified the expression of BCA-1 mRNA by malignant B cells, but not vascular endoth
108 ed that the number of exchanged hydrogens of BCA was higher when the protein was bound to a ligand wi
109 he stability of a rung of a charge ladder of BCA to denaturation with SDS.
110                               High levels of BCA-1 (CXCL13) were also found on endothelial cells in s
111          If another small molecule ligand of BCA is dissolved in the solution, the rate of protein ef
112 r the differences in selectivity profiles of BCA and SCA processes.
113 patients who underwent surgical resection of BCA or BCAC were identified.
114  glycine chain destabilizes the structure of BCA in a length-dependent manner, causing an increase in
115 idea that charged residues on the surface of BCA do not guide protein folding and raises the broader
116 interact hydrophobically with the surface of BCA.
117 ty that was cryptic to karyotyping in 21% of BCAs, highlighting the limitations of conventional cytog
118                            At least 33.9% of BCAs resulted in gene disruption that likely contributed
119                 We explored the landscape of BCAs at nucleotide resolution in 273 subjects with a spe
120 cortisone produced an elevation in levels of BCAs and their metabolites which were lowered by insulin
121                     The direct modulation of BCAs by glucocorticoids and insulin may provide the basi
122 d by SNAP were eliminated by pretreatment of BCAs with DPI under 21% O(2) but not under N(2).
123 These results demonstrate that the HIV-1 p24 BCA assay offers 100-150-fold enhancement in the detecti
124 e carbonic anhydrase (BCA) and peracetylated BCA (BCA-Ac(18))--having the same sequence of amino acid
125 (HA, 100 mum), altered the NPV to PGF2alpha (BCA increased, HA inhibited) and/or LY83583 (BCA increas
126 hest dose of hydrocortisone increased plasma BCAs in both insulin groups but increased free fatty aci
127  hydrated CO2 species, apparently preventing BCA from catalyzing the dehydration reaction.
128 oryl and silyl conjugate addition reactions (BCA and SCA, respectively), which proceed without the ne
129                                  Remarkably, BCA breakpoints in eight subjects altered a single TAD e
130 ciation of Atox1 and the binding of a second BCA to generate apo-Atox1 and Cu-BCA(2).
131  the Atox1-Cu-BCA intermediate by the second BCA.
132                                 We sequenced BCAs in patients with autism or related NDDs, revealing
133                     Moreover, submicroscopic BCAs and subarray threshold CNVs are intractable, or cry
134 nt the first experimental demonstration that BCA is not the rigid, static globulin that has been typi
135                                 We find that BCA is relatively fouling-resistant.
136                                          The BCA assay is a colorimetric method for estimating protei
137 the aortic root (P < 0.01) and by 50% at the BCA (P < 0.05) in fractalkine-deficient females at 16 we
138 ctalkine-deficient mice appears to be at the BCA rather than the aortic root.
139  thus, their fluorescence is quenched by the BCA chromophore (lambda(max) 562 nm).
140                             Furthermore, the BCA assay detected HIV-1 infection 3 days earlier than d
141 uses europium NPs to replace gold NPs in the BCA assay to further simplify the detection method and d
142 ally unfolded intermediate stabilized in the BCA II folding/unfolding reaction, and it could be used
143                         The reduction in the BCA population size was relatively small within 8 days;
144 *2 results in the transient formation of the BCA*1*CB[7] and BCA*2*CB[7] ternary complexes that under
145 ydrogens with increasing chain length of the BCA-bound ligand, across the series.
146 o overcome this limitation, we performed the BCA assays in opaque, white 384-well plates.
147  healthy plant tissues and the time that the BCA remains active are two of the more important factors
148 cy, it is necessary to frequently apply this BCA with the application interval depending on the growt
149 ccessfully adapted to the synthesis of three BCAs with great interest especially for biomedical appli
150                         Addition of CB[7] to BCA*1 and BCA*2 results in the transient formation of th
151 rity of the immobilized ligands are bound to BCA.
152 ully detected the binding of brinzolamide to BCA II, a non-two-state folding protein.
153 l zone and peritoneal B1 B cells, respond to BCA-1, implying that responsiveness to this follicular c
154                              Taken together, BCA represents a natural phytoestrogen that mitigates st
155 tal fate of Bacillus subtilis, a widely used BCA, focusing on its dispersal aspect in open field and
156 rison to controls, brucite carbonation using BCA was accelerated by up to 240%.
157 on for future physical-organic studies using BCA as a model to examine interactions between proteins
158 factors did not reliably predict BCAC versus BCA (sensitivity, 81%; specificity, 21%).
159 rm outcomes were associated with BCAC versus BCA, as well as the presence of spindle cell/ovarian str
160               On pathology most lesions were BCA (89.1%), whereas 27 (10.9%) were BCAC.
161                                      Whereas BCA-1 was not detected in normal human brain, all 24 bra
162  Alkaline brucite slurries were amended with BCA and supplied with 10% CO2 gas while aqueous chemistr
163 other dietary protein is not associated with BCA.
164                                Children with BCA were breast-fed for a slightly longer duration than
165                 The beads are incubated with BCA and allowed to reach an equilibrium state in which t
166 /6 mice were intraperitoneally injected with BCA (5 and 10 mg/kg) for 4 wk and subjected to ischemic
167  the inhibitory effects of DPI compared with BCAs that were not treated with dithionite.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top